Focal therapy for moderate and high-risk prostate cancer

Debater-Pro(s)

• 

  Behfar Ehdaie, MD

  Memorial Sloan Kettering

Debater-Con(s)

• 

  Kelly L. Stratton, MD

  Associate Professor
  Department of Urology, Stephenson Cancer Center, University of Oklahoma